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Ahmad K Darwazah* and Hamdy El SayedAbstract
Giant left atrium is a condition characterized by huge enlargement of the left atrium with a diameter exceeding
65mm. It is most commonly associated with long standing rheumatic mitral valve disease. We present a 45-year-old
female patient with rheumatic mitral stenosis associated with giant left atrium occupied by an 11 × 10 × 5 cm
thrombus weighing 500 gms. The patient underwent successful mitral valve replacement and thrombectomy
through an inverted T-shaped biatrial incision.
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Giant left atrium (GLA) is commonly associated with
long standing rheumatic mitral valve regurgitation or
mixed mitral disease with predominant regurgitation [1].
The exact etiology is not known. Both increased left atrial
pressure and weakening of left atrial wall by rheumatic
pancarditis are implicated in its development [1,2].
The condition can be associated with atrial fibrillation,
thromboembolic complications, hemodynamic and re-
spiratory complications [3]. We present a case of GLA
with predominant mitral stenosis associated with atrial
fibrillation and huge thrombus formation. The patient
was successfully managed by mitral valve replacement
and removal of LA thrombus.
Case presentation
A 45-year-old woman with a known history of rheumatic
mitral stenosis presented with a 9 months history of pro-
gressive shortness of breath and bilateral peripheral
oedema.
The patient had a successful closed mitral valvotomy
in 1987, from which she completely recovered and was
maintained on digoxin and warfarin.
Few months before admission her activity became limi-
ted due to increase shortness of breath, repeated coughing
and recurrent paroxysmal nocturnal dyspnea. She was
treated with aggressive diuretic regimen, digoxin, corda-
rone, beta-blockers and warfarin.* Correspondence: darwaz30@hotmail.com
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distribution, and reproduction in any mediumPhysical examination revealed signs of right sided
heart failure with decrease air entry along both lung
bases. A mid-diastolic murmur was heard at the apex
together with pansystolic murmur at left lower paraster-
nal region.
Electrocardiography showed atrial fibrillation with en-
larged right ventricle. Marked cardiomegaly was seen on
chest radiography (Figure 1). A hugely enlarged left atrium
(11 × 10 cm) occupied by a thrombus was demonstrated
by transthoracic echocardiography (Figure 2). Evidence of
mitral restenosis (MVA 0.9 cm2) with mild regurgitation
was seen. Tricuspid valve was severely incompetent with
an estimated PAP of 75 mmHg.
Laboratory investigations revealed a low hemoglobin
level (9.5 g/dL), low platelets count (135,000/cmm),
mildly elevated liver enzymes with positive hepatitis C
antibodies.
Abdominal ultrasound showed hepatomegaly with
mild cirrhosis as well as mild splenomegaly.
Surgery was performed using standard CPB with mode-
rate hypothermia and antegrade blood cardioplegia. The
stenosed mitral valve was exposed through an inverted
T-shaped biatrial incision. A huge organized thrombus
measuring 11 × 10 × 5 cm was removed (Figure 3). Mitral
valve was replaced with St. Jude Medical valve 31-mm.
Tricuspid valve was repaired using Devag’s annuloplasty.
Minimal inotropic support was used during weaning from
bypass.
Postoperatively, the patient remained hemodynami-
cally stable. She was ventilated for 17 hours and haded Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Preoperative chest x-ray showing marked
cardiomegally and widening of the carina.
Figure 3 A thrombus measuring 11 x 10 x 5 cm removed from
the left atrium.
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which intensive chest physiotherapy was performed. The
patient was discharged after 12 days.
Follow-up by TTE and chest X-ray two weeks after sur-
gery showed a well functioning prosthetic valve, clear left
atrium with an estimated size of 9 × 9.8 cm (Figure 4).
Both lung fields were clear with reduced cardiothoracic
ratio (Figure 5).Figure 2 Preoperative echocardiography showing a huge left
atrium occupied by a thrombus.Discussion
Long standing mitral valve disease is associated with en-
largement of the left atrium as a compensatory mecha-
nism due to increase intracavitary pressure and volume.
Such an enlargement is beneficial as it reduces pulmon-
ary congestion, thus it protects the lung from pulmonary
hypertension and oedema [4]. However, with gradual
increase in left atrial pressure an associated increase in
pulmonary venous pressure will eventually occur [2].
Extreme enlargement of the left atrium more than
65mm is known as giant left atrium (GLA) [3]. Its exact
etiology is still unknown. The condition has been closely
related to rheumatic mitral valve regurgitation or mixed
mitral valve disease causing severe pressure and volume
overload [1]. However, the condition can be associated
with mitral valve prolapse, heart failure, chronic atrialFigure 4 Postoperative echocardiography showing a reduction
of left atrial size.
Figure 5 Postoperative chest x-ray showing reduction of
cardiothoracic ratio.
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seen in patients with normal mitral valve function [2].
The mechanism of formation of GLA is not fully
understood. Patients with chronic mitral valve disease
are not always associated with GLA. Only 19% may de-
velop such a condition [6]. Previous studies showed that
chronic pressure in the left atrium is not the only cause
of GLA, but weakening of the left atrial wall by rheuma-
tic pancarditis causing chronic inflammation and fibrosis
is also implicated [1-3].
Enlargement of the left atrium is associated with de-
velopment of atrial fibrillation, which in return can lead
to further enlargement of left atrium. Such an observa-
tion was seen among patients who had atrial fibrillation
with absence of cardiac pathology [7].
Huge enlargement of the left atrium is prone to
develope various complications including thrombus for-
mation, thromboembolic events, hemodynamic derange-
ments and sudden death [3,8].
Patients with GLA are usually presented with symp-
toms related to mitral valve disease. Specific symptoms
may occur due to compression of the oesophagus and
airway by the enlarged posterior wall of the left atrium
causing dysphagia and respiratory dysfunction. Cardiac
output may be reduced by obstruction of inferior vena
cava due to displacement of atrial septum and compres-
sion of the postero-lateral wall of the left ventricle by
the enlarged left atrium [8]. In rare situations, patients
are completely asymptomatic [9].
The enlarged left atrium is associated with blood stasis
and thrombus formation. The risk of thrombo embolism
increases with left atrial size regardless of anticoagula-
tion [8]. Previous studies found that the incidence of leftatrial thrombus among patients with mitral stenosis as-
sociated with AF varies from 7-38%. Such an incidence
is directly related to the size of left atrium [6,10].
It is interesting to note that not all patients with GLA
have an associated thrombus formation [11,12]. Also the
size of thrombus varies from one patient to the other
[9,13]. Such a diversity can be explained by various local
factors in the left atrium.
Goldsmith and colleagues [14], found that patients
with mitral valve disease have associated left atrial en-
docardial damage. They found that severe damage was
encountered among patients with mitral stenosis associ-
ated with AF. Such damage contributed to the risk of
thrombus formation. The other factor is related to the
activation of coagulation system within the left atrium
[15]. Patients with mitral stenosis have a significantly
high level of fibrinopeptide A, thrombin-antithrombin
III complex and Von Willebrand factor antigen in the
left atrium. These biochemical markers are responsible
for the formation of thrombosis even during anticoagu-
lation regardless of the severity of mitral stenosis or size
of left atrium [15].
Our patient had a longstanding mitral stenosis asso-
ciated with chronic AF. Both factors were responsible
for the development of GLA and thrombosis. Despite
the high incidence of rheumatic valvular heart disease in
Egypt, GLA is seen in only 3-4% of our patients. Such a
low incidence is probably related to early development
of pulmonary hypertension and its subsequent effect on
reducing right ventricular output, so both pressure and
volume load in left atrium are reduced.
The size of thrombus in our patient was huge in com-
parison to previously reported cases despite the fact, that
the size of the left atrium in our patient was smaller. It
is important to mention that the development of throm-
bosis in our patient occurred despite therapeutic anti-
coagulation and without any evidence of interruption of
oral anticoagulant. These observations agree with previ-
ous studies which emphasized the importance of local
factors within the left atrium.
Controversies still exist regarding surgical manage-
ment of GLA by atrial plication. Previous studies showed
that plication at the time of mitral valve surgery is essen-
tial to reduce left atrial size to eliminate its compressing
symptoms and thromboembolic complications(3). How-
ever, such a procedure is associated with various compli-
cations as circumflex coronary artery injury, pulmonary
vein obstruction and oesophageal stricture [16].
A previous study by Tonguc and colleagues [16], com-
pared patients undergoing mitral valve replacement
(MVR) with or without plication, found no significant
difference in hemodynamic improvement and reduction
of left atrial diameter especially when the diameter was
below 80 mm.
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showed no difference whether plication was performed
or not [17]. Plication of the left atrium was not
performed in our patient, to avoid unnecessary compli-
cations. Adhesions from previous surgery, postoperative
bleeding due to low platelet count, history of hepatitis C
virus and cirrhotic liver were our main concern.
We agree with other investigators [8], that the size of
left atrium will not change significantly after MVR due
to irreversible damage of left atrial muscle by fibrosis.
But we believe that hemodynamics will improve after
MVR with or without plication.
The most striking compressive symptom in our patient
was on the respiratory system. Although, the size of the
left atrium did not change much in the early postopera-
tive period, the reduction in the left atrial pressure and
pulmonary artery pressure were sufficient to alleviate the
respiratory symptoms. Postoperative chest X-ray showed
significant improvement of both lung fields and wide-
ning of the carina.
Removal of an organized thrombus from the left
atrium can be challenging especially when it is huge in
size. The presence of dense adhesions and absence of
cleavage plane makes its removal difficult [18]. Under
these circumstances, residual organized material can be
left. Lim and colleagues [18], suggested the use of au-
tologous pericardial patch to cover these areas to avoid
future thrombus formation.
Thrombectomy in our patients was easy to perform
despite the huge size. This was facilitated by performing
an inverted T-shaped biatrial incision. A line of cleavage
was identified and the whole thrombus was completely
removed intact.
Early postoperative anticoagulation was of a great con-
cern in the present case. Our patient had multiple factors
which can predispose to early thrombosis, among which
are, the giant left atrium, associated atrial fibrillation,
rough left atrial cavity after thrombectomy and finally the
newly implanted mechanical mitral prosthesis.
Various strategies of using early postoperative oral
anticoagulation with or without heparin have been
reported, but the optimal method to reduce the incidence
of thrombosis and to avoid hemorrhagic complications is
still debatable.
Oral anticoagulants alone seems to be a safe approach to
reduce thrombosis and bleeding [19]. However, such medi-
cations are not ideal for early use since several days are
usually required to achieve therapeutic INR. The addition
of heparin within 24 hours after surgery in combination
with oral anticoagulants was recommended to cover the
early critical period after valve implantation [20].
Comparing the effect of various types of heparin in re-
lation to thrombosis and bleeding, various studies found
that the use of intravenous unfractionated heparin havethe highest incidence in comparison to prophylactic dose
of sc unfractionated or LMW heparin [21].
Concerning our present case, a single dose of intraven-
ous unfractionated heparin 5000 u was used few hours
after surgery after checking coagulation profile and chest
drains for bleeding. Oral Coumadin 5 mg loading dose
and aspirin 80 mg together with sc prophylactic dose of
LMW heparin(clexane) were commenced on the first
day posoperatively. Once therapeutic INR (2.5-3) was
reached, heparin was discontinued.
Our policy to use intravenous unfractionated early
postoperatively instead of LMW heparin, is to be able to
control any possible risk of bleeding which might occur.
Unfractionated heparin can be fully reversed by prota-
mine when compared with LMW heparin.
The addition of low dose of aspirin with oral anticoa-
gulants potentiates the reduction of thromboembolism
[21], thus reducing the dose of oral anticoagulants and
the incidence of bleeding complications among these
patients.Conclusions
GLA can be associated with huge thrombus formation.
Various factors are implicated in the formation of
thrombosis, among which the local left atrial factors
seem to play a major role. Complete removal of huge
thrombus can be facilitated by the use of an inverted
T- shaped biatrial incision.Consent
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